GlassScriptPhysician profile
Shawn Nash
NPI 1801203088
$2,235.70
in general payments reported to CMS, 2019-2025
15 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.39 · 2023: $17.09 · 2024: $781 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,145 · Honoraria: $38.86 · Gift: $21.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,144.98 |
| Honoraria | $38.86 |
| Gift | $21.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $977.79 | 2023-2025 | Clareon, Tryptyr, Acrysof Iq Panoptix Uv Iol |
| Sun Pharmaceutical Industries INC. | $242.08 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $238.65 | 2024-2025 | Xiidra, Miebo, Scoutpro Osmolarity System |
| Tarsus Pharmaceuticals, INC. | $132.41 | 2024-2025 | Xdemvy |
| Astellas Pharma Global Development | $115.11 | 2025 | Izervay |
| Rxsight INC | $103.74 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Biotissue Holdings INC. | $102.57 | 2025 | |
| Abbvie INC. | $68.66 | 2024-2025 | |
| Ocular Therapeutix, INC. | $68.21 | 2024-2025 | Dextenza |
| Apellis Pharmaceuticals, INC. | $51.80 | 2025 | Syfovre |
| Thea Pharma INC. | $39.18 | 2025 | Iyuzeh |
| Biohorizons Implant Systems INC. | $30.39 | 2019 | |
| Astellas Pharma US INC | $25.79 | 2024 | Izervay |
| New World Medical,INC. | $19.85 | 2025 | Clearpath, Ahmed Glaucoma Valve, Via360 |
| Oyster Point Pharma, INC. | $19.47 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.